Smith, Moore & Co. »

Revolution Medicines shares owned by Smith, Moore & Co.

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Smith, Moore & Co. from 13F filings

Historical chart of Smith, Moore & Co. investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Smith, Moore & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Smith, Moore & Co.

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 7.0k 187.28
2026-03-31 $584k 6.0k 97.25
2025-12-31 $478k 6.0k 79.65
2025-09-30 $280k 6.0k 46.70

More positions owned by Smith, Moore & Co.

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares S&p 500 Value Etf Etf (IVE)
Bondbloxx Bloomberg One Year Target Duration Us Treasury Etf Etf (XONE)
State Street Spdr S&p Midcap 400 Etf Trust Etf (MDY)
Apple Stock (AAPL)
Ishares Russell 1000 Growth Etf Etf (IWF)
State Street Spdr S&p 500 Etf Etf (SPY)
Ishares Core S&p Small Cap Etf Etf (IJR)
Invesco Qqq Trust Series I Etf (QQQ)
Capital Group Dividend Value Etf Etf (CGDV)
Fundstrat Granny Shots Us Large Cap Etf Etf (GRNY)
Vanguard Dividend Appreciation Etf Etf (VIG)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Vanguard Ftse Developed Markets Etf Etf (VEA)

View all positions for Smith, Moore & Co.

Top funds holding Revolution Medicines

BlackRock
Farallon Capital Management
FMR
Baker Bros. Advisors
Jupiter Topco
Darwin Global Management
Henderson Group
Vanguard Capital Management
Vanguard Portfolio Management
Nextech Invest
Paradigm Biocapital Advisors
UBS Group
State Street Corporation
Geode Capital Management
Wellington Management Company

View all funds holding Revolution Medicines